OT: A choice between [Design Issues]

posted by BEQool  – 2024-10-23 15:17 (198 d 15:22 ago) – Posting: # 24248
Views: 3,809

Hello Helmut,

of course I unfortunately dont know the answers to your questions but

❝ [...] or PEs by model 3 (i.e., the conventional one with any group terms)? What would an assessor conclude from any of those? Even if they would calculate the CI of groups separately, likely they would overlap. So what?


Isnt it so that if we detect Group*Treatment interaction, the CIs of groups seperately very likely wouldnt overlap? That is why we detect an interaction?

BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
73 visitors (0 registered, 73 guests [including 7 identified bots]).
Forum time: 06:39 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5